Exelixis Inc (EXEL)
22.52
+0.02
(+0.11%)
USD |
NASDAQ |
Apr 19, 16:00
22.52
0.00 (0.00%)
After-Hours: 18:05
Exelixis Price: 22.52 for April 19, 2024
Price Chart
Historical Price Data
| Date | Open | High | Low | Close | Volume |
|---|---|---|---|---|---|
| Apr 18, 2024 | 23.00 | 23.22 | 22.46 | 22.49 | 2.604M |
| Apr 17, 2024 | 22.90 | 23.29 | 22.82 | 22.87 | 2.795M |
| Apr 16, 2024 | 22.60 | 23.08 | 22.53 | 22.82 | 1.694M |
| Apr 15, 2024 | 22.93 | 23.06 | 22.64 | 22.70 | 1.784M |
| Apr 12, 2024 | 22.70 | 23.04 | 22.63 | 22.81 | 1.943M |
| Apr 11, 2024 | 23.37 | 23.39 | 22.42 | 22.65 | 2.358M |
| Apr 10, 2024 | 23.57 | 23.80 | 23.38 | 23.68 | 1.477M |
| Apr 09, 2024 | 23.33 | 23.74 | 23.28 | 23.72 | 1.294M |
| Apr 08, 2024 | 23.02 | 23.42 | 22.85 | 23.35 | 1.677M |
| Apr 05, 2024 | 23.42 | 23.45 | 23.08 | 23.14 | 1.942M |
| Apr 04, 2024 | 23.85 | 23.96 | 23.38 | 23.49 | 2.294M |
| Apr 03, 2024 | 23.34 | 23.84 | 23.34 | 23.69 | 1.782M |
| Apr 02, 2024 | 23.53 | 23.59 | 23.24 | 23.34 | 2.349M |
| Apr 01, 2024 | 23.57 | 23.70 | 23.22 | 23.68 | 2.017M |
| Mar 28, 2024 | 23.93 | 23.98 | 22.70 | 23.73 | 2.953M |
| Mar 27, 2024 | 23.78 | 23.90 | 23.66 | 23.86 | 1.616M |
| Mar 26, 2024 | 23.70 | 23.80 | 23.58 | 23.61 | 1.880M |
| Mar 25, 2024 | 23.75 | 23.93 | 23.65 | 23.70 | 2.258M |
| Mar 22, 2024 | 24.02 | 24.05 | 23.77 | 23.78 | 1.934M |
| Mar 21, 2024 | 23.82 | 24.07 | 23.56 | 23.92 | 2.686M |
| Mar 20, 2024 | 23.41 | 23.73 | 23.28 | 23.71 | 2.232M |
| Mar 19, 2024 | 23.19 | 23.51 | 23.18 | 23.47 | 2.408M |
| Mar 18, 2024 | 23.14 | 23.42 | 23.06 | 23.17 | 2.386M |
| Mar 15, 2024 | 22.62 | 23.02 | 22.55 | 22.98 | 4.872M |
| Mar 14, 2024 | 23.02 | 23.10 | 22.40 | 22.61 | 2.472M |
Price Definition
The price of a security measures the cost to purchase 1 share of a security. For a company, price can be multiplied by shares outstanding to find the market capitalization (value of the company).
Price Range, Past 5 Years
14.46
Minimum
Mar 16 2020
27.42
Maximum
May 11 2020
20.24
Average
20.20
Median
Jun 07 2019
Price Benchmarks
| Regeneron Pharmaceuticals Inc | 896.26 |
| Bristol-Myers Squibb Co | 48.92 |
| Incyte Corp | 52.30 |
| Bio-Techne Corp | 62.12 |
| Legend Biotech Corp | 46.20 |
Price Related Metrics
| PE Ratio | 35.00 |
| PS Ratio | 3.955 |
| PEG Ratio | 2.723 |
| Price to Book Value | 3.015 |
| Price to Free Cash Flow | 42.49 |
| Earnings Yield | 2.86% |
| Market Cap | 6.826B |
| PEGY Ratio | 2.723 |
| Operating PE Ratio | 42.35 |
| Normalized PE Ratio | 35.00 |